BIROn - Birkbeck Institutional Research Online

    The use of botulinum toxin in the treatment of adductor spasmodic dysphonia

    Whurr, R. and Lorch, Marjorie and Fontana, H. and Brookes, G.B. and Lees, A.J. and Marsden, C.D. (1993) The use of botulinum toxin in the treatment of adductor spasmodic dysphonia. Journal of Neurology, Neurosurgery & Psychiatry 56 (5), pp. 526-530. ISSN 0022-3050.

    Full text not available from this repository.

    Abstract

    Botulinum toxin injections have been used to treat 31 patients with adductor spasmodic dysphonia. Injections of 3.00-3.75 units of botulinum toxin were performed bilaterally into the thyroarytenoid muscle. This treatment significantly decreased the standard deviation of the fundamental frequency of the speech sample, indicating a reduction in the variability of pitch amongst patients. A total of 96% of patients' subjective diary reports showed an improvement with a median of 7 days to peak effect and a 5 week duration of peak effect.

    Metadata

    Item Type: Article
    School: Birkbeck Faculties and Schools > Faculty of Humanities and Social Sciences > School of Creative Arts, Culture and Communication
    Depositing User: Administrator
    Date Deposited: 27 Sep 2011 10:42
    Last Modified: 09 Aug 2023 12:31
    URI: https://eprints.bbk.ac.uk/id/eprint/4157

    Statistics

    Activity Overview
    6 month trend
    0Downloads
    6 month trend
    340Hits

    Additional statistics are available via IRStats2.

    Archive Staff Only (login required)

    Edit/View Item Edit/View Item